Compare UMH & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UMH | PRCT |
|---|---|---|
| Founded | 1968 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1995 | 2021 |
| Metric | UMH | PRCT |
|---|---|---|
| Price | $15.29 | $17.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 15 |
| Target Price | $18.88 | ★ $22.25 |
| AVG Volume (30 Days) | 593.2K | ★ 1.3M |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 5.91% | N/A |
| EPS Growth | ★ 133.33 | 1.71 |
| EPS | ★ 0.08 | N/A |
| Revenue | $261,754,000.00 | ★ $308,054,000.00 |
| Revenue This Year | $8.48 | $28.32 |
| Revenue Next Year | $7.59 | $20.48 |
| P/E Ratio | $190.38 | ★ N/A |
| Revenue Growth | 8.81 | ★ 37.22 |
| 52 Week Low | $13.93 | $16.67 |
| 52 Week High | $16.77 | $38.11 |
| Indicator | UMH | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 45.44 | 45.00 |
| Support Level | $15.13 | $16.84 |
| Resistance Level | $15.79 | $29.27 |
| Average True Range (ATR) | 0.24 | 0.99 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 56.25 | 35.14 |
UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.